Oligo cyc-DEP: On-chip cyclic immunofluorescence profiling of cell-derived nanoparticles.
dielectrophoresis
early cancer detection
liquid biopsy
microfluidics
oligo‐tagged antibody
Journal
Electrophoresis
ISSN: 1522-2683
Titre abrégé: Electrophoresis
Pays: Germany
ID NLM: 8204476
Informations de publication
Date de publication:
25 Jul 2024
25 Jul 2024
Historique:
revised:
29
06
2024
received:
29
04
2024
accepted:
10
07
2024
medline:
26
7
2024
pubmed:
26
7
2024
entrez:
25
7
2024
Statut:
aheadofprint
Résumé
We present a follow-on technique for the cyclic-immunofluorescence profiling of suspension particles isolated using dielectrophoresis. The original lab-on-chip technique ("cyc-DEP" [cyclic immunofluorescent imaging on dielectrophoretic chip]) was designed for the multiplex surveillance of circulating biomarkers. Nanoparticles were collected from low-volume liquid biopsies using microfluidic dielectrophoretic chip technology. Subsequent rounds of cyclic immunofluorescent labeling and quenching were imaged and quantified with a custom algorithm to detect multiple proteins. While cyc-DEP improved assay multiplicity, long runtimes threatened its clinical adoption. Here, we modify the original cyc-DEP platform to reduce assay runtimes. Nanoparticles were formulated from human prostate adenocarcinoma cells and collected using dielectrophoresis. Three proteins were labeled on-chip with a mixture of short oligonucleotide-conjugated antibodies. The sample was then incubated with complementary fluorophore-conjugated oligonucleotides, which were dehybridized using an ethylene carbonate buffer after each round of imaging. Oligonucleotide removal exhibited an average quenching efficiency of 98 ± 3% (n = 12 quenching events), matching the original cyc-DEP platform. The presented "oligo cyc-DEP" platform achieved clinically relevant sample-to-answer times, reducing the duration for three rounds of cyclic immunolabeling from approximately 20 to 6.5 h-a 67% decrease attributed to rapid fluorophore removal and the consolidated co-incubation of antibodies.
Identifiants
pubmed: 39049673
doi: 10.1002/elps.202400088
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University
ID : Full Project 5640519
Informations de copyright
© 2024 The Author(s). Electrophoresis published by Wiley‐VCH GmbH.
Références
Connal S, Cameron JM, Sala A, Brennan PM, Palmer DS, Palmer JD, et al. Liquid biopsies: the future of cancer early detection. J Transl Med. 2023;21:118.
Ibsen SD, Wright J, Lewis JM, Kim S, Ko SY, Ong J, et al. Rapid isolation and detection of exosomes and associated biomarkers from plasma. ACS Nano. 2017;11(7):6641–6651.
Lewis JM, Dhawan S, Obirieze AC, Sarno B, Akers J, Heller MJ, et al. Plasma biomarker for post‐concussive syndrome: a pilot study using an alternating current electro‐kinetic platform. Front Neurol [Internet]. 2020 [cited 2023 Sep 10];11. https://www.frontiersin.org/articles/10.3389/fneur.2020.00685
Lewis JM, Vyas AD, Qiu Y, Messer KS, White R, Heller MJ. Integrated analysis of exosomal protein biomarkers on alternating current electrokinetic chips enables rapid detection of pancreatic cancer in patient blood. ACS Nano. 2018;12(4):3311–3320.
Lewis J, Alattar AA, Akers J, Carter BS, Heller M, Chen CC. A pilot proof‐of‐principle analysis demonstrating dielectrophoresis (DEP) as a glioblastoma biomarker platform. Sci Rep. 2019;9(1):10279.
Hinestrosa JP, Searson DJ, Lewis JM, Kinana A, Perrera O, Dobrovolskaia I, et al. Simultaneous isolation of circulating nucleic acids and EV‐associated protein biomarkers from unprocessed plasma using an AC electrokinetics‐based platform. Front Bioeng Biotechnol. [Internet]. 2020 [cited 2023 Sep 10];8. Available from: https://www.frontiersin.org/articles/10.3389/fbioe.2020.581157
Hinestrosa JP, Kurzrock R, Lewis JM, Schork NJ, Schroeder G, Kamat AM, et al. Early‐stage multi‐cancer detection using an extracellular vesicle protein‐based blood test. Commun Med. 2022;2(1):1–9.
Dhani H, Hinestrosa JP, Izaguirre‐Carbonell J, Balcer HI, Kurzrock R, Billings PR. Case report: early detection of pancreatic pre‐cancer lesion in multimodal approach with exosome liquid biopsy. Front Oncol. [Internet]. 2023 [cited 2023 Sep 10];13. Available from: https://www.frontiersin.org/articles/10.3389/fonc.2023.1170513
Ding Z, Wang N, Ji N, Chen ZS. Proteomics technologies for cancer liquid biopsies. Mol Cancer. 2022;21(1):53.
Gustafson KT, Sayar Z, Le H, Gustafson SL, Gower A, Modestino A, et al. cyc‐DEP: cyclic immunofluorescence profiling of particles collected using dielectrophoresis. Electrophoresis. 2022;43(16–17):1784–1798.
Lin JR, Fallahi‐Sichani M, Chen JY, Sorger PK. Cyclic immunofluorescence (cycIF), a highly multiplexed method for single‐cell imaging. Curr Protoc Chem Biol. 2016;8(4):251–264.
Lin JR, Fallahi‐Sichani M, Sorger PK. Highly multiplexed imaging of single cells using a high‐throughput cyclic immunofluorescence method. Nat Commun. 2015;6(1):8390.
McMahon NP, Jones JA, Anderson AN, Dietz MS, Wong MH, Gibbs SL. Flexible cyclic immunofluorescence (cyCIF) using oligonucleotide barcoded antibodies. Cancers. 2023;15(3):827.
Jones JA, McMahon NP, Zheng T, Eng J, Chin K, Kwon S, et al. Oligonucleotide conjugated antibody strategies for cyclic immunostaining. Sci Rep. 2021;11(1):23844.
Black S, Phillips D, Hickey JW, Kennedy‐Darling J, Venkataraaman VG, Samusik N, et al. CODEX multiplexed tissue imaging with DNA‐conjugated antibodies. Nat Protoc. 2021;16(8):3802–3835.
He S, Bhatt R, Brown C, Brown EA, Buhr DL, Chantranuvatana K, et al. High‐plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. Nat Biotechnol. 2022;40(12):1794–1806.
McMahon N, Jones J, Eng J, Kwon S, Chang YH, Thibault G, et al. Signal removal methods for highly multiplexed immunofluorescent staining using antibody conjugated oligonucleotides. Proc SPIE–Int Soc Opt Eng. 2019;10881:108810X.
McMahon N, Jones J, Solanki A, Eng J, Kwon S, Chang YH, et al. Antibody conjugated oligonucleotides as a platform for cyclic immunofluorescent staining. Microsc Microanal. 2019;25(S2):1206–1207.
McMahon NP, Jones JA, Kwon S, Chin K, Nederlof MA, Gray JW, et al. Oligonucleotide conjugated antibodies permit highly multiplexed immunofluorescence for future use in clinical histopathology. J Biomed Opt. 2020;25(5):056004.
Yilmaz LS, Loy A, Wright ES, Wagner M, Noguera DR. Modeling formamide denaturation of probe‐target hybrids for improved microarray probe design in microbial diagnostics. PLOS ONE. [Internet]. [cited 2024 Feb 18]. Available from: https://journals.plos.org/plosone/article?id
Blake RD, Delcourt SG. Thermodynamic effects of formamide on DNA stability. Nucleic Acids Res. 1996;24(11):2095–2103.
Matthiesen SH, Hansen CM. Fast and non‐toxic in situ hybridization without blocking of repetitive sequences. PLOS ONE. 2012;7(7):e40675.
Moffitt JR, Hao J, Wang G, Chen KH, Babcock HP, Zhuang X. High‐throughput single‐cell gene‐expression profiling with multiplexed error‐robust fluorescence in situ hybridization. Proc Natl Acad Sci. 2016;113(39):11046–11051.
Huber D, Kaigala GV. Rapid micro fluorescence in situ hybridization in tissue sections. Biomicrofluidics. 2018;12(4):042212.
Golczyk H. A simple non‐toxic ethylene carbonate fluorescence in situ hybridization (EC‐FISH) for simultaneous detection of repetitive DNA sequences and fluorescent bands in plants. Protoplasma. 2019;256(3):873–880.
Nguyen HT, Dupont LN, Cuttaz EA, Jean AM, Trouillon R, Gijs MAM. Breast cancer HER2 analysis by extra‐short incubation microfluidics‐assisted fluorescence in situ hybridization (ESIMA FISH). Microelectron Eng. 2018;189:33–38.
Civitci F, Shangguan J, Zheng T, Tao K, Rames M, Kenison J, et al. Fast and multiplexed superresolution imaging with DNA‐PAINT‐ERS. Nat Commun. 2020;11(1):4339.
Rames MJ, Kenison JP, Heineck D, Civitci F, Szczepaniak M, Zheng T, et al. Multiplexed and millimeter‐scale fluorescence nanoscopy of cells and tissue sections via prism‐illumination and microfluidics‐enhanced DNA‐PAINT. Chem Biomed Imaging. 2023;1(9):817–830.
Sisson BA, Uvalic J, Kelly K, Selvam P, Hesse AN, Ananda G, et al. Technical and regulatory considerations for taking liquid biopsy to the clinic: validation of the JAX PlasmaMonitorTM assay. Biomark Insights. 2019;14:1177271919826545.
Duijvesz D, Rodriguez‐Blanco G, Hoogland AM, Verhoef EI, Dekker LJ, Roobol MJ, et al. Differential tissue expression of extracellular vesicle‐derived proteins in prostate cancer. Prostate. 2019;79(9):1032–1042.
Brzozowski JS, Bond DR, Jankowski H, Goldie BJ, Burchell R, Naudin C, et al. Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion. Sci Rep. 2018;8(1):8822.
Manouchehri Doulabi E, Fredolini C, Gallini R, Löf L, Shen Q, Ikebuchi R, et al. Surface protein profiling of prostate‐derived extracellular vesicles by mass spectrometry and proximity assays. Commun Biol. 2022;5:1402.
Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue‐based map of the human proteome. Science. 2015;347(6220):1260419.
Gustafson KT, Huynh KT, Heineck D, Bueno J, Modestino A, Kim S, et al. Automated fluorescence quantification of extracellular vesicles collected from blood plasma using dielectrophoresis. Lab Chip. 2021;21(7):1318–1332.
Stoeckius M, Zheng S, Houck‐Loomis B, Hao S, Yeung BZ, Mauck WM, et al. Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 2018;19(1):224.
Stoeckius M, Hafemeister C, Stephenson W, Houck‐Loomis B, Chattopadhyay PK, Swerdlow H, et al. Simultaneous epitope and transcriptome measurement in single cells. Nat Methods. 2017;14(9):865–868.
Turner R, Madsen J, Herrera PDS, Wallace J, Madrigal J, Hinestrosa JP, et al. Cancer detection at your fingertips: smartphone‐enabled DNA testing. In: 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) [Internet]. 2018 [cited 2024 Jun 15]. Available from: https://ieeexplore.ieee.org/document/8513553
Kinkhabwala A, Herbel C, Pankratz J, Yushchenko DA, Rüberg S, Praveen P, et al. MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci Rep. 2022;12(1):1911.
Wiener J, Kokotek D, Rosowski S, Lickert H, Meier M. Preparation of single‐ and double‐oligonucleotide antibody conjugates and their application for protein analytics. Sci Rep. 2020;10(1):1457.